Used in clinical research for the treatment of osteoarthritis, particularly targeting pain associated with the condition by inhibiting fatty acid amide hydrolase (FAAH), which increases levels of endogenous cannabinoids that modulate pain and inflammation. It has been investigated for its potential to provide analgesic effects without the side effects commonly associated with opioids or NSAIDs. Studies have also explored its use in other pain-related disorders and neurological conditions involving the endocannabinoid system.